Stock listing
gettex:ET8 COSCIENS Biopharma Inc. Aktie
German listing (gettex) of COSCIENS Biopharma Inc. · home listing TSX:CSCI
Follow COSCIENS Biopharma Inc. into a list and get an email when it puts out news.
Home listing price · TSX:CSCI
$8.60 CAD -0.18 (-2.1%)
Close on Oct 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, TSX:CSCI
- Day range
- $8.60 – $8.60 CADOct 20, 2026
- Volume
- 100 sharesOct 20, 2026
- Market cap
- $8.58M CADAt the close on Oct 20, 2026 · price × 997,219 shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TSX:CSCI · Home | $8.60 CAD | -0.18 (-2.1%) | 100 | $8.60 | $8.60 | $8.60 | $8.78 | Close on Oct 20, 2026 |
| OTC:CSCIF | $6.49 USD | 0.00 (0.0%) | — | $6.49 | $6.49 | $6.49 | $6.49 | Close on Oct 19, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · TSX:CSCI · CAD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $8.60 | -0.18 | -2.1% | $8.60 | $8.60 | $8.60 | 100 | |
| $8.78 | -0.38 | -4.1% | $8.78 | $8.78 | $8.78 | 356 | |
| $9.16 | +0.26 | +2.9% | $9.16 | $9.16 | $9.16 | 100 | |
| $8.90 | -0.70 | -7.3% | $9.50 | $9.50 | $8.90 | 1,700 | |
| $9.60 | -0.10 | -1.0% | $9.60 | $9.60 | $9.60 | 101 | |
| $9.70 | +0.10 | +1.0% | $9.80 | $9.80 | $9.70 | 350 | |
| $9.60 | -0.29 | -2.9% | $9.60 | $9.60 | $9.60 | 168 | |
| $9.89 | +0.71 | +7.7% | $9.28 | $9.89 | $9.28 | 709 | |
| $9.18 | +0.48 | +5.5% | $8.88 | $9.94 | $8.88 | 1,702 | |
| $8.70 | -0.18 | -2.0% | $8.76 | $8.76 | $8.70 | 1,603 | |
| $8.88 | +0.13 | +1.5% | $8.88 | $8.88 | $8.88 | 100 | |
| $8.75 | -0.50 | -5.4% | $9.10 | $9.10 | $8.75 | 732 | |
| $9.25 | +0.65 | +7.6% | $8.96 | $9.25 | $8.96 | 211 | |
| $8.60 | +0.21 | +2.5% | $8.50 | $10.00 | $8.40 | 3,803 | |
| $8.39 | +0.39 | +4.9% | $7.51 | $8.39 | $7.51 | 500 | |
| $8.00 | +0.50 | +6.7% | $7.58 | $8.20 | $7.58 | 2,343 | |
| $7.50 | -0.10 | -1.3% | $7.50 | $7.50 | $7.50 | 408 | |
| $7.60 | +0.15 | +2.0% | $7.60 | $7.60 | $7.60 | 100 | |
| $7.45 | -0.20 | -2.6% | $7.46 | $7.46 | $7.45 | 200 | |
| $7.65 | +0.04 | +0.5% | $7.99 | $8.00 | $7.65 | 1,952 | |
| $7.61 | 0.00 | 0.0% | $7.51 | $7.61 | $7.51 | 1,000 | |
| $7.61 | +0.21 | +2.8% | $7.61 | $7.61 | $7.61 | 501 | |
| $7.40 | -0.10 | -1.3% | $7.50 | $7.50 | $7.40 | 1,706 | |
| $7.50 | +0.25 | +3.4% | $7.50 | $7.50 | $7.50 | 100 | |
| $7.25 | -0.05 | -0.7% | $7.25 | $7.25 | $7.25 | 138 | |
| $7.30 | -0.20 | -2.7% | $7.30 | $7.30 | $7.10 | 1,626 | |
| $7.50 | +0.26 | +3.6% | $7.40 | $7.50 | $7.40 | 1,001 | |
| $7.24 | -0.06 | -0.8% | $7.26 | $7.26 | $7.24 | 1,902 | |
| $7.30 | -0.65 | -8.2% | $7.30 | $7.30 | $7.30 | 300 | |
| $7.95 | +0.01 | +0.1% | $7.95 | $7.95 | $7.95 | 501 | |
| $7.94 | +0.60 | +8.2% | $7.50 | $7.94 | $7.50 | 810 | |
| $7.34 | -0.54 | -6.9% | $7.51 | $7.75 | $7.00 | 2,400 | |
| $7.88 | +0.02 | +0.3% | $7.86 | $7.88 | $7.86 | 786 | |
| $7.86 | +0.24 | +3.1% | $7.77 | $7.86 | $7.77 | 2,001 | |
| $7.62 | +0.37 | +5.1% | $7.72 | $7.72 | $7.62 | 900 | |
| $7.25 | +0.20 | +2.8% | $7.06 | $7.25 | $7.06 | 602 | |
| $7.05 | -0.02 | -0.3% | $7.25 | $7.25 | $7.05 | 300 | |
| $7.07 | -0.03 | -0.4% | $7.05 | $7.07 | $7.05 | 636 | |
| $7.10 | 0.00 | 0.0% | $7.00 | $8.10 | $7.00 | 1,361 | |
| $7.10 | -0.05 | -0.7% | $7.10 | $7.10 | $7.08 | 652 | |
| $7.15 | -0.75 | -9.5% | $7.11 | $7.15 | $7.10 | 419 | |
| $7.90 | 0.00 | 0.0% | $7.56 | $7.90 | $7.00 | 3,434 | |
| $7.90 | +0.20 | +2.6% | $7.90 | $7.90 | $7.90 | 261 | |
| $7.70 | -0.05 | -0.6% | $7.85 | $7.85 | $7.70 | 414 | |
| $7.75 | +0.13 | +1.7% | $7.75 | $7.75 | $7.75 | 1,141 | |
| $7.62 | -0.13 | -1.7% | $7.56 | $7.62 | $7.52 | 1,204 | |
| $7.75 | +0.20 | +2.6% | $7.76 | $7.76 | $7.56 | 1,000 | |
| $7.55 | -0.45 | -5.6% | $7.90 | $7.90 | $7.55 | 2,791 |
- Ticker
- gettex:ET8
- Asset type
- Stock
- Exchange
- gettex
- Currency
- EUR
What changed lately
Latest news release · Oct 19, 2026
COSCIENS announces new corporate presentation and provides update on convertible debenture offering
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 14 slides
Latest news
COSCIENS announces new corporate presentation and provides update on convertible debenture offering
Oct 19, 2026
Closed $8.78 (-4.1%) on Oct 19, 2026
COSCIENS completes second tranche of convertible debenture offering
Sep 16, 2026
Closed $7.60 (+2.0%) on Sep 18, 2026
COSCIENS acquires nualtis corp.
Sep 10, 2026
Closed $7.65 (+0.5%) on Sep 11, 2026
COSCIENS Biopharma Inc. Reports Q2 2026 Results
Aug 11, 2026
Closed $7.86 (+3.1%) on Aug 12, 2026
Financings
Private placement of 15% unsecured convertible debentures
Oct 19, 2026
Tranche closed: US$12M raised
Insiders: Certain directors and officers are participating for an aggregate principal amount of approximately US$1.3 million
Use of proceeds: Together with existing cash, to pay the remaining US$6 million deferred purchase price for the Nualtis acquisition due March 2027
Tranche closed Sep 10, 2026 · Tranche closed Sep 16, 2026 · Tranche closed Oct 19, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 14 slides · September 2026
Aeterna Zentaris — Investor Presentation (January 2022)
Investor deck · 30 slides · Jan 26, 2022
Aeterna Zentaris — Investor Presentation (October 2021)
Investor deck · 29 slides · Oct 7, 2021
Aeterna Zentaris — H.C. Wainwright 23rd Annual Global Investment Conference 2021
Conference · 27 slides · Sep 13, 2021
COSCIENS Biopharma Inc. on 6ix
- News releases
- 16 in the last 12 months · 229 in all · newest Oct 19, 2026 · oldest 2011
- Decks
- 7 decks · latest September 2026
Where COSCIENS Biopharma Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TSX:CSCI · Home listing | TSX | Canada | CAD |
| OTC:CSCIF | OTC | United States | USD |
| Lang & Schwarz:A40J1L | Lang & Schwarz | Germany | EUR |
| LS Exchange:A40J1L | LS Exchange | Germany | EUR |
| gettex:ET8 · This page | gettex | Germany | EUR |
| Frankfurt:ET8 | Frankfurt | Germany | EUR |
| LSE:0UGB | LSE | United Kingdom | CAD |
| Cboe Canada:CSCI | Cboe Canada | Canada | CAD |
| Dusseldorf:ET8 | Dusseldorf | Germany | EUR |
| Munich:ET8 | Munich | Germany | EUR |
| Stuttgart:ET8 | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about COSCIENS Biopharma Inc.